Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series C Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 24 $ 239,256 $ (234,078) $ 5,202
Beginning balance, shares at Dec. 31, 2019 249 2,434,009      
Extinguishment of derivative liability upon exercise of warrant 1,557 1,557
Issuance of common stock upon exercise of warrants for cash
Issuance of common stock from the exercise of warrants for cash, shares     100      
Issuance of common stock from the cashless exercise of warrants $ 32 (32)
Issuance of common stock from the cashless exercise of warrants, shares     3,128,895      
Preferred stock issued for cash, net of fees 3,112 3,112
Preferred stock issued for cash, shares   9,440        
Common stock issued on conversion of preferred stock $ 62 (62)
Common stock issued on conversion of preferred stock, shares   (9,208) 6,215,742      
Issuance of agent warrants 168 168
Beneficial conversion feature on issuance of convertible preferred stock 3,111 3,111
Deemed dividend related to the issuance of preferred stock (3,111) (3,111)
Accretion of convertible preferred stock discount 6,173 6,173
Deemed dividend related to the conversion of preferred stock (6,173) (6,173)
Net income (loss) 1,169 1,169
Ending balance, value at Mar. 31, 2020 $ 118 243,999 (232,909) 11,208
Ending balance, shares at Mar. 31, 2020 249 232 11,778,746      
Beginning balance, value at Dec. 31, 2019 $ 24 239,256 (234,078) 5,202
Beginning balance, shares at Dec. 31, 2019 249 2,434,009      
Net income (loss)           (5,297)
Ending balance, value at Sep. 30, 2020 $ 246 266,665 (239,375) 27,536
Ending balance, shares at Sep. 30, 2020 26 51 24,551,059      
Beginning balance, value at Mar. 31, 2020 $ 118 243,999 (232,909) 11,208
Beginning balance, shares at Mar. 31, 2020 249 232 11,778,746      
Extinguishment of derivative liability upon exercise of warrant 1,451 1,451
Common stock issued for cash, net of fees $ 65 9,583 9,648
Common stock issued for cash, net of fees, shares     6,454,381      
Issuance of common stock upon exercise of warrants for cash $ 6 911 917
Issuance of common stock from the exercise of warrants for cash, shares     611,868      
Issuance of common stock from the cashless exercise of warrants $ 3 (3)
Issuance of common stock from the cashless exercise of warrants, shares     373,750      
Common stock issued on conversion of preferred stock $ 2 (2)
Common stock issued on conversion of preferred stock, shares (123) (179) 212,168      
Accretion of convertible preferred stock discount 207 207
Deemed dividend related to the conversion of preferred stock (207) (207)
Net income (loss) (4,028) (4,028)
Ending balance, value at Jun. 30, 2020 $ 194 255,939 (236,937) 19,196
Ending balance, shares at Jun. 30, 2020 126 53 19,430,913      
Stock based compensation 29 29
Extinguishment of derivative liability upon exercise of warrant 190 190
Common stock issued for cash, net of fees $ 50 10,318 10,368
Common stock issued for cash, net of fees, shares     4,915,000      
Issuance of common stock upon exercise of warrants for cash $ 1 190 191
Issuance of common stock from the exercise of warrants for cash, shares     127,650      
Issuance of common stock from the cashless exercise of warrants
Issuance of common stock from the cashless exercise of warrants, shares     1,890      
Common stock issued on conversion of preferred stock $ 1 (1)
Common stock issued on conversion of preferred stock, shares (100) (2) 75,606      
Accretion of convertible preferred stock discount 74 74
Deemed dividend related to the conversion of preferred stock (74) (74)
Net income (loss) (2,438) (2,438)
Ending balance, value at Sep. 30, 2020 $ 246 266,665 (239,375) 27,536
Ending balance, shares at Sep. 30, 2020 26 51 24,551,059      
Beginning balance, value at Dec. 31, 2020 $ 245 266,666 (241,107) 25,804
Beginning balance, shares at Dec. 31, 2020 26 51 24,552,409      
Stock based compensation 36 36
Extinguishment of derivative liability upon exercise of warrant 195 195
Issuance of common stock upon exercise of warrants for cash $ 2 194 196
Issuance of common stock from the exercise of warrants for cash, shares     130,275      
Issuance of common stock from the cashless exercise of warrants
Issuance of common stock from the cashless exercise of warrants, shares     1,890      
Net income (loss) (2,633) (2,633)
Ending balance, value at Mar. 31, 2021 $ 247 267,091 (243,740) 23,598
Ending balance, shares at Mar. 31, 2021 26 51 24,684,574      
Beginning balance, value at Dec. 31, 2020 $ 245 266,666 (241,107) 25,804
Beginning balance, shares at Dec. 31, 2020 26 51 24,552,409      
Net income (loss)           (7,175)
Ending balance, value at Sep. 30, 2021 $ 247 267,275 (248,282) 19,240
Ending balance, shares at Sep. 30, 2021 26 51 24,706,074      
Beginning balance, value at Mar. 31, 2021 $ 247 267,091 (243,740) 23,598
Beginning balance, shares at Mar. 31, 2021 26 51 24,684,574      
Stock based compensation 80 80
Stock based compensation, shares     15,500      
Net income (loss) (2,199) (2,199)
Ending balance, value at Jun. 30, 2021 $ 247 267,171 (245,939) 21,479
Ending balance, shares at Jun. 30, 2021 26 51 24,700,074      
Stock based compensation 104 104
Stock based compensation, shares     6,000      
Net income (loss) (2,343) (2,343)
Ending balance, value at Sep. 30, 2021 $ 247 $ 267,275 $ (248,282) $ 19,240
Ending balance, shares at Sep. 30, 2021 26 51 24,706,074